期刊文献+

心源性恶液质患者的临床特点及预后影响因素 被引量:2

下载PDF
导出
摘要 目的探讨心源性恶液质(CC)的临床特点及预后影响因素。方法将168例慢性心力衰竭(CHF)患者分为CC组46例和CHF组122例;两组行人体测量评估和常用营养指标检测(血红蛋白、白蛋白、转铁蛋白、前白蛋白、胆固醇和甘油三酯)。结果与CHF组比较,CC组血红蛋白、前白蛋白和胆固醇水平均明显降低(P均<0.05),服用ACEI/ARB以及β-受体阻滞剂的比例明显降低(P均<0.05)。结论血红蛋白、前白蛋白、胆固醇是反映CC的有用指标,应用ACEI/ARB以及β-受体阻滞剂可预防CC的发生。
出处 《山东医药》 CAS 北大核心 2011年第33期72-73,共2页 Shandong Medical Journal
  • 相关文献

参考文献9

  • 1Neubauer S.The failing heart:an engine out of fuel[J].N Engl J Med,2007,356(11):1140-1151.
  • 2Swedberg K,Cleland J,Dargie H,et al.Guidelines for the diagnosis and treatment of chronic heart failure:executive summary (update 2005):The task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology[J].Eur Heart J,2005,26(11):1115-1140.
  • 3Anker SD,Ponikowski P,Varney S,et al.Wasting as independent risk factor for mortality in chronic heart failure[J].Lancet,1997,349(9058):1050-1053.
  • 4Anker SD,Steinborn W,Starssburg S.Cardiac cachexia[J].Ann Med,2004,36(7):518-529.
  • 5Kyle UG,Besaeus I,de Lorenzo AD,et al.Bioelectrical impedance analysis:utilization in clinical practice[J].Clin Nutr,2004,23(6):i430-1453.
  • 6von Haehling S,Lainscak M,Springer J,et al.Cardiac cachexia:a systematic overview[J].Pharm Ther,2009,121 (3):227-252.
  • 7Hrnciarikova D,Juraskova B,Hysper R,et al.A changed view of serum pre-albumin in the elderly:pre-albumin values influenced by concomitant inflammation[J].Biomed Pap Med Fac Univ Palcky Olomouc Czech Repub,2007,151 (2):273-276.
  • 8Anker SD,Doehner W,Rauchhaus M,et al.Uric acid and survival in chronic heart failure:validation and application in metabolic,functional,and hemodynamic staging[J].Circulation,2003,107(15):1991-1997.
  • 9Flather MD,Shibata MC.For the SENIORS Investigators.Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)[J].Eur Heart J,2005,26(3):215-225.

同被引文献36

  • 1毛琳.心脏性恶病质综合征36例报告[J].医学综述,1996,2(5):237-238. 被引量:3
  • 2Kataoka H.Short term changes in hematologic and biochemical tests during follow-up of definite heart failure patients [J].Int J Cardiol, 2010,144(3):441-444.
  • 3Pittman JG,Cohen P.The Pathogenesis of cardiac cachexia [J].N Engl Med, 1964,271 (8):403-409.
  • 4Cart JG, Stevenson LW,Walden JA,et al.Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure seoandary to ischemic or idiopathic dilated cardiomyopathy [J].Am J Cardiol, 1989,63(3):709-713.
  • 5Schwengal RH,Gottlieb SS,Fisher ML.Protein-energy malnutrition in patients with ischemic and nonischemic dilated cardiomyopathy and congestive heart failure[J].Am J Cardiol, 1994,73(5):908-910.
  • 6Heymsfield SB,Casper K.Congestive heart failure clinical management by use of continuous nasoenteric feeding [J].Am J Clin Nutr,1985,50 (3):539-544.
  • 7von Haehling S, Lainscak M, Springer J, et al. Cardiac cachexia:a systematic overview[J]. Pharmacol Ther, 2009,121 (3):227-252.
  • 8Haider M,Haider SQ.Assessment of protein-calorie malnutrition [J] . Clin Chem,1984, 30(8):1286-1299.
  • 9Araujo JP, Lourenco P, Rocha-Goncalves F, et al. Nutritional markers and prognosis in cardiac cachexia [J]. Int J Cardiol, 2011, 146 (3): 359-363.
  • 10Ajayi AA, Adigun AQ, Ojofeitimi EO, et al. Anthropometric evaluati- on of cachexia in chronic congestive heart failure:the role of tricuspid regurgitation[J]. Int J Cardio1,1999, 71(1):79-84.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部